Level of Physical Activities in Patients Before and After Breast Cancer Treatment (PABC)

Tracking Information
First Submitted Date ICMJE	August 14, 2007
First Posted Date ICMJE	August 16, 2007
Last Update Posted Date	May 30, 2014
Study Start Date ICMJE	May 2006
Primary Completion Date	Not Provided
Current Primary Outcome Measures ICMJE; (submitted: August 15, 2007)	breast cancer [ Time Frame: one year ]
Original Primary Outcome Measures ICMJE	Same as current
Change History	Complete list of historical versions of study NCT00517088 on ClinicalTrials.gov Archive Site
Current Secondary Outcome Measures ICMJE	Not Provided
Original Secondary Outcome Measures ICMJE	Not Provided
Current Other Outcome Measures ICMJE	Not Provided
Original Other Outcome Measures ICMJE	Not Provided
Descriptive Information
Brief Title ICMJE	Level of Physical Activities in Patients Before and After Breast Cancer Treatment
Official Title ICMJE	Level of Physical Activities in Patients Before and After Breast Cancer Treatment
Brief Summary	Subjects and Methods: 303 patients who had already had the diagnosis of breast cancer and had already been treated at the Ambulatory of Botucatu School of Medicine were selected. The measuring tool used for the level of physical activities was the International Physical Activities Questionnaire (IPAQ-short version), validated by the World Health Organization - Physical Activities and Health International Committee (1998).
Detailed Description	Introduction: Breast cancer is the most common malignant neoplasy in women. The risk for breast cancer in a lifetime is high among north-american women, about one out of eight, with 66% of the cases occurring after menopause and 15% when women are under 40 years old. Published cohort studies show clear evidences that women who practice intense physical activities have the risk for breast cancer reduced. The risk reduction for these women is 70%, and 10% for those who practice physical activities at a low level. During adolescence and adult age, moderate to intense physical activities may protect against a future breast cancer development. But some questions still need to be answered: Were women with a breast carcinoma diagnosis already physically active during life? Were there changes in these physical activities after treatment? Why? Objectives: The aim of this study was to identify the level of physical activities in patients before and after breast carcinoma treatment, and to observe if there were changes in the level of these activities. Subjects and Methods: 303 patients who had already had the diagnosis of breast cancer and had already been treated at the Ambulatory of Botucatu School of Medicine were selected. The measuring tool used for the level of physical activities was the International Physical Activities Questionnaire (IPAQ-short version), validated by the World Health Organization - Physical Activities and Health International Committee (1998).
Study Type ICMJE	Interventional
Study Phase	Not Applicable
Study Design ICMJE	Intervention Model: Single Group Assignment; Masking: Single (Participant)
Condition ICMJE	Breast Cancer
Intervention ICMJE	Drug: IPAQ
Study Arms	Other; Group Description; Intervention: Drug: IPAQ
Publications *	Not Provided
* Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
Recruitment Information
Recruitment Status ICMJE	Completed
Actual Enrollment ICMJE; (submitted: August 15, 2007)	2007
Original Actual Enrollment ICMJE	Same as current
Actual Study Completion Date	March 2007
Primary Completion Date	Not Provided
Eligibility Criteria ICMJE	Inclusion Criteria: Patients whit diagnosis of breast cancer
Sex/Gender	Sexes Eligible for Study: Female
Ages	20 Years to 90 Years (Adult, Senior)
Accepts Healthy Volunteers	Yes
Contacts ICMJE	Contact information is only displayed when the study is recruiting subjects
Listed Location Countries ICMJE	Not Provided
Removed Location Countries
Administrative Information
NCT Number ICMJE	NCT00517088
Other Study ID Numbers ICMJE	upeclin/HC/FMB-Unesp-pre03
Has Data Monitoring Committee	Yes
U.S. FDA-regulated Product	Not Provided
IPD Sharing Statement	Not Provided
Responsible Party	Not Provided
Study Sponsor ICMJE	UPECLIN HC FM Botucatu Unesp
Collaborators ICMJE	Not Provided
Investigators ICMJE	Principal Investigator: Flávio G Pinto UPECLIN HC FM Botucatu Unesp
PRS Account	UPECLIN HC FM Botucatu Unesp
Verification Date	August 2007
ICMJE Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP